Coloplast Ownership

CLPBY Stock  USD 12.58  0.07  0.56%   
Coloplast holds a total of 2.12 Billion outstanding shares. Almost 99.99 percent of Coloplast outstanding shares are held by general public with 0.01 % by other corporate entities. On June 8, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of Coloplast A's common stock.
Some institutional investors establish a significant position in pink sheets such as Coloplast in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Coloplast, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coloplast A. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Coloplast Pink Sheet Ownership Analysis

The company last dividend was issued on the 2nd of December 2022. Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast is traded on OTC Exchange in the United States.The quote for Coloplast A is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Coloplast A please contact the company at 45 49 11 11 11 or go to https://www.coloplast.com.

Coloplast's latest congressional trading

Congressional trading in companies like Coloplast A, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Coloplast by those in governmental positions are based on the same information available to the general public.
2024-06-08Representative Josh GottheimerAcquired Under $15KVerify

Coloplast Outstanding Bonds

Coloplast issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Coloplast A uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Coloplast bonds can be classified according to their maturity, which is the date when Coloplast A has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Coloplast Pink Sheet Analysis

When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.